STOCK TITAN

Ellomay Cap Financials

ELLO
FY2025 annual
Revenue $50.3M +19.4% YoY
Net Income -$7.5M +20.1% YoY
EPS (Diluted) -$0.19 YoY not available
Free Cash Flow -$112.0M -65.7% YoY
Source SEC Filings (10-K/10-Q) Data as of Apr 30, 2026 Currency USD FYE April

Ellomay Cap (ELLO) reported $50.3M in revenue for fiscal year 2025, up 19.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ELLO FY2025

Ellomay’s reported growth engine is balance-sheet expansion, with new assets funded mainly by capital inflows rather than operating cash.

Across the last three fiscal years, asset growth and cash generation moved in opposite directions: the asset base kept expanding while operating cash flow weakened, so FY2025 capex was covered only 2.5% by operating cash. That helps explain why cash reached $102.9M even though the business still needed $164.9M of financing inflow to keep investing.

Accounting earnings understate the funding need here: the net loss was $7.5M, but free cash flow was -$112.0M because reinvestment remained far larger than cash coming out of operations. The practical point is that reported profit or loss is not the main constraint; access to funding is.

Reported leverage looks mild if you stop at debt-to-equity of 0.2x. But total liabilities were about 4.1x equity, and liquidity only recently moved back above 1.0x, so the balance sheet carries more fixed obligations than the debt line alone suggests. That improvement in short-term liquidity reads as financing-led rather than internally generated.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 36 / 100
Financial Health Score 36/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ellomay Cap's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
85
Dilution
57
R&D Intensity
0

Not available for Ellomay Cap, and counted as zero in the overall score.

Revenue Progress
43
Burn Trend
0

Not available for Ellomay Cap, and counted as zero in the overall score.

Balance Sheet
28
Piotroski F-Score Partial
4/8

Ellomay Cap passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
N/A

Ellomay Cap reported a net loss of $7.5M while generating $2.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$50.3M
YoY+19.4%

Ellomay Cap generated $50.3M in revenue in fiscal year 2025. This represents an increase of 19.4% from the prior year.

Net Income
-$7.5M
YoY+20.1%

Ellomay Cap reported -$7.5M in net income in fiscal year 2025. This represents an increase of 20.1% from the prior year.

EPS (Diluted)
-$0.19

Ellomay Cap earned -$0.19 per diluted share (EPS) in fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$112.0M
YoY-65.7%

Ellomay Cap recorded an outflow of $112.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 65.7% from the prior year.

Cash & Debt
$102.9M
YoY+113.2%

Ellomay Cap held $102.9M in cash against $41.7M in long-term debt as of fiscal year 2025.

Shares Outstanding
14M

Ellomay Cap had 14M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin
-14.9%
YoY+7.4pp

Ellomay Cap's net profit margin was -14.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.4 percentage points from the prior year.

Return on Equity
-3.9%
YoY+2.3pp

Ellomay Cap's ROE was -3.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.3 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures
$114.9M
YoY+51.3%

Ellomay Cap invested $114.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 51.3% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

ELLO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ELLO annual income statement
MetricFY25FY24FY23FY22FY21
Revenue$50.3M+19.4%$42.1M-22.0%$54.0M-5.1%$56.9M+12.3%$50.7M
Interest Expense-$4.6MN/AN/AN/AN/A
Income Tax-$3.0M-100.3%-$1.5M+6.7%-$1.6M-170.8%$2.2M+179.6%-$2.8M
Net Income-$7.5M+20.1%-$9.4M-1452.7%$693K+371.4%$147K+100.6%-$22.9M
EPS (Diluted)-$0.19-$0.54$0.34N/AN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income.

ELLO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ELLO annual balance sheet
MetricFY25FY24FY23FY22FY21
Total Assets$990.4M+40.5%$705.0M+4.0%$677.8M+10.3%$614.5M-1.5%$623.8M
Current Assets$134.1M+104.9%$65.4M-36.9%$103.7M+50.4%$69.0M-27.3%$94.9M
Cash & Equivalents$102.9M+113.2%$48.2M-9.3%$53.2M+3.6%$51.4M+16.9%$44.0M
Accounts Receivable$8.5M+51.3%$5.6M-57.7%$13.3M-1.9%$13.5M+26.0%$10.7M
Total Liabilities$796.5M+39.6%$570.4M+5.7%$539.5M+2.6%$525.9M+6.2%$495.3M
Current Liabilities$108.0M+19.7%$90.2M-7.9%$98.0M+0.8%$97.2M-58.1%$232.3M
Long-Term Debt$41.7M+58.1%$26.4M+0.6%$26.2M+11.6%$23.5M+31.2%$17.9M
Total Equity$193.9M+27.9%$151.6M+16.5%$130.2M+41.7%$91.9M-24.5%$121.7M
Retained Earnings-$16.1M-33.6%-$12.0M-116.0%-$5.6M+28.0%-$7.7M+5.3%-$8.2M

Not reported in any period shown, so not listed: Inventory, Goodwill.

ELLO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ELLO annual cash flow statement
MetricFY25FY24FY23FY22FY21
Operating Cash Flow$2.9M-65.5%$8.3M-12.8%$9.5M-21.1%$12.1M-30.0%$17.2M
Capital Expenditures$114.9M+51.3%$75.9M+16.6%$65.1M+25.6%$51.8M-44.7%$93.7M
Free Cash Flow-$112.0M-65.7%-$67.6M-21.7%-$55.6M-39.7%-$39.8M+48.0%-$76.5M
Investing Cash Flow-$117.1M-74.6%-$67.1M-9.2%-$61.4M-104.4%-$30.1M+75.3%-$121.6M
Financing Cash Flow$164.9M+268.6%$44.7M-25.7%$60.2M+112.9%$28.3M-53.9%$61.3M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ELLO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ELLO annual financial ratios
MetricFY25FY24FY23FY22FY21
Net Margin-14.9%+7.4pp-22.3%-23.5pp1.3%+1.0pp0.3%+45.5pp-45.3%
Return on Equity-3.9%+2.3pp-6.2%-6.7pp0.5%+0.4pp0.2%+19.0pp-18.9%
Return on Assets-0.8%+0.6pp-1.3%-1.4pp0.1%+0.1pp0.0%+3.7pp-3.7%
Current Ratio1.24+0.5x0.73-0.3x1.06+0.3x0.71+0.3x0.41
Debt-to-Equity0.210.0x0.170.0x0.20-0.1x0.26+0.1x0.15
FCF Margin-222.7%-160.5%-102.9%-69.9%-150.9%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Similar Companies

Frequently Asked Questions

What is Ellomay Cap's annual revenue?

Ellomay Cap (ELLO) reported $50.3M in total revenue for fiscal year 2025. This represents a 19.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ellomay Cap's revenue growing?

Ellomay Cap (ELLO) revenue grew by 19.4% year-over-year, from $42.1M to $50.3M in fiscal year 2025.

Is Ellomay Cap profitable?

No, Ellomay Cap (ELLO) reported a net income of -$7.5M in fiscal year 2025, with a net profit margin of -14.9%.

Ellomay Cap (ELLO) reported diluted earnings per share of -$0.19 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Ellomay Cap (ELLO) had $102.9M in cash and equivalents against $41.7M in long-term debt.

Ellomay Cap (ELLO) had a net profit margin of -14.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ellomay Cap (ELLO) has a return on equity of -3.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ellomay Cap (ELLO) recorded an outflow of $112.0M in free cash flow during fiscal year 2025. This represents a -65.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ellomay Cap (ELLO) generated $2.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ellomay Cap (ELLO) had $990.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Ellomay Cap (ELLO) invested $114.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ellomay Cap (ELLO) had 14M shares outstanding as of fiscal year 2025.

Ellomay Cap (ELLO) had a current ratio of 1.24 as of fiscal year 2025, which is considered adequate.

Ellomay Cap (ELLO) had a debt-to-equity ratio of 0.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ellomay Cap (ELLO) had a return on assets of -0.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Ellomay Cap (ELLO) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ellomay Cap (ELLO) reported a net loss of $7.5M while generating $2.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ellomay Cap (ELLO) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top